University of Minnesota. Driven to Discover.
As cases soar in both the UK and South Africa, scientists are scrambling to detail variant virus characteristics.
Regulators in Africa are reviewing the vaccine for licensing in at-risk countries.
Flu hospitalizations are also on the rise, with the highest levels in seniors, a pattern often seen in H3N2-dominant seasons.
More states are reporting their first cases and even deaths, but at the national level, flu levels remained low last week.
The study of VSV-EBOV hopes to enroll 6,000 health and other frontline workers.
With its Mar 7 launch date, the trial's main goal is to see if ring vaccination can knock down Ebola hot spots.
An international team of experts says, in effect, "Don't be so sure" about Ebola not spreading by air.
An efficacy trial could start in Liberia in December, according to WHO.
Experts today pushed for new ways to test Ebola treatments, and two groups renewed their urgent pleas for aid.
Canada, Britain announce enhanced screening, as officials in Spain probe how a health worker was infected.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2022 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.